Lord's Mark Industries Receives License for India's First Gut Microbiome Analytics Platform
Lord's Mark Industries Limited has become India's first company to receive a manufacturing license for its Biomescan Analytics Platform, an In Vitro Diagnostic Software for gut microbiome analysis. The platform offers personalized insights into gut microbial diversity, metabolic functions, and disease risk, supporting preventive healthcare and wellness. Positioned within a growing gut health market, Biomescan aims to facilitate early health management and personalized nutrition, with a focus on fertility-related benefits. It is licensed as a wellness tool, not for clinical diagnosis or treatment decisions.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (78/100). Lens Score 38/100.
Outlets measured: thetribune, republicworld. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (78–78/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
republicworld broke this story on 11 Aug, 08:56 am. Other outlets followed.